Wells Fargo’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
Wells Fargo's RLYB Position: Q3 2026 in Review
Wells Fargo sold out of Rallybio (RLYB) in Q3 2026, closing a stake of 74 shares — an estimated $592 sold.
Wells Fargo first reported a position in RLYB in Q3 2021 and held it in 20 quarters. The position peaked at $67.2K in Q2 2023. 32 funds tracked by Wall St. Rank hold RLYB as of Q3 2026.
- Wells Fargo reported no remaining Rallybio position as of Q3 2026 after selling out during the quarter.
- Wells Fargo sold 74 Rallybio shares in Q3 2026, an estimated $592.
- Wells Fargo first reported a position in Rallybio in Q3 2021 and held it in 20 quarters.
- Wells Fargo's Rallybio position peaked at $67.2K in Q2 2023.
- 32 funds tracked by Wall St. Rank held Rallybio as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.